about
Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplifi...
Read More
2.70
-0.18
(-6.25%)
170.1K
XNAS Volume
XNAS 23 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Boundless Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..